由于2型自体主导性低血症和术后副甲状腺功能障碍症的组合而导致的耐火性低血症
Melda Sonmez Ince1, Nazanene H Esfandiari1, Fadil M Hannan2
1Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
概括
一名患有慢性低血症的患者因GNA11变异而被诊断为2型自体主导低血症 (ADH2). 这一案例突出了管理共同存在的遗传性和术后偏偏甲状腺症的挑战.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 一名49岁的女性出现了20年的慢性低血病史.
- 她的血清含量在6.4-8.5mg/dL之间,甲状腺上腺激素 (PTH) 不适当低至低正常.
- 在为乳头甲状腺癌进行全甲状腺切除术后,她出现了严重的,有症状的,耐火性低血症,无法检测到PTH.
研究的目的:
- 在患有慢性低血病史和甲状腺切除术后的甲状腺缺血症患者中调查耐火性低血症的遗传基础.
- 描述与2型自体主导低血症 (ADH2) 相关的临床表现和遗传发现.
- 探讨管理综合遗传和获得性低甲状腺症患者的挑战.
主要方法:
- 临床病例介绍和综述.
- 血清和副甲状腺激素水平的生物化学分析.
- 基因测序以确定致病变体.
- 副甲状腺组织的病理检查.
主要成果:
- 手术后的病理学揭示了一个单个高细胞副甲状腺.
- 遗传评估发现了一种致病性GNA11变体 (c.178C>T,p.Arg60Cys),证实了2型自体主导性低血症 (ADH2).
- 尽管进行了积极的医疗管理,包括输注糖酸,血清仍然持续低.
结论:
- 这一案例扩大了对ADH2的理解,ADH2是一种影响平衡的罕见遗传疾病.
- 患者的演讲强调了因遗传倾向和手术干预的相互作用而导致的低血症管理的复杂性.
- 对于具有共同存在的遗传性和术后偏偏甲状腺症患者的最佳治疗策略需要进一步调查.
相关概念视频
The Parathyroid Glands
5.5K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
5.5K
Skeleton and Calcium Homeostasis
6.3K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
6.3K
Hormones and Bone Tissue
4.0K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.0K
Synthesis and Functions of Calcitonin
4.9K
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
4.9K
Bone Remodeling
40.7K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.7K
Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K


